Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Halozyme Therapeutics (HALO) and Amicus Therapeutics (FOLD). But which of these two ...
Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $46.96 which represents a decrease of $-0.36 or -0.76% from the prior close of $47.32. The stock opened at $47.03 and touched ...
Results that may be inaccessible to you are currently showing.